SoCalBio Panel Outlines Practical Steps for AI in Clinical Care

In a press release, leaders at the 27th Annual SoCalBio Conference in Los Angeles outlined how artificial intelligence can move from hype to practical use in clinical settings. The panel included representatives from RKS Design, NeuraSignal, Avenda Health, DigitalDx Ventures, and Johnson & Johnson.

The session, titled "The Role of AI in Driving Better Patient Outcomes from Diagnosis to Recovery," focused on aligning AI tools with clinical workflows and reimbursement models. Panelists emphasized that administrative automation will likely deliver earlier benefits than diagnostic or treatment applications, which require longer evidence development.

Key recommendations included designing AI systems that reduce clinician workload, ensuring usability and reimbursement are considered together, building trust with diverse datasets and transparent model updates, and adhering to FDA guidance while recognizing that live-learning systems are still emerging. The discussion also highlighted the importance of shared metrics and integration standards to help healthcare providers evaluate performance and adoption readiness.